Government use licenses in Thailand: The power of evidence, civil movement and political leadership Suwit Wibulpolprasert1, Vichai Chokevivat2, Cecilia Oh3 and Inthira Yamabhai3* 3Health Intervention and Technology Assessment Program Abstract This paper attempts to describe and analyse t

Human papillomavirus vaccine introduction in low and middle income countries: guidance on the use of cost-effectiveness models Mark Jit1, Nadia Demarteau2†, Elamin Elbasha3†, Gary Ginsberg4†, Jane Kim5†, Naiyana Praditsitthikorn6†, Edina Sinanovic7† and Raymond Hutubessy8* † Contributed equally 8

Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand Pattara Leelahavarong1*, Yot Teerawattananon1, Pitsaphun Werayingyong1, Chutima Akaleephan2, Nakorn Premsri3, Chawetsan Namwat3, Wiwat Peerapatanapoki

Government use licenses in Thailand: an assessment of the health and economic impacts Inthira Yamabhai, Adun Mohara, Sripen Tantivess*, Kakanang Chaisiri and Yot Teerawattananon. Health Intervention and Technology Assessment Program (HITAP) Background Between 2006 and 2008, Thailand’s Mi

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions Download at http://www.resource-allocation.com/content/9/1/8 Sitaporn Youngkong1,2*, Noor Tromp1† and Dereck Chitama1,3† * Corresponding author: Sitaporn Youngkong [email protected]

Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand Naiyana Praditsitthikorn,1,2 Yot Teerawattananon,1,3 Sripen Tantivess,1,3 Supon Limwattananon,3 Arthorn Riewpaiboon,2 Saibua Chichareon,4 Nantakan Ieumwananonthachai5 and Viroj Tangcharoensathien3

Abstract: There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This paper describes the evidence and decision-making of the National List of Essential Medicines Committee that recently announced the inclusi

Impact of the Introduction of Government Use Licences on the Drug Expenditure on Seven Medicines in Thailand. Adun Mohara, MSccorrespondenceemail, Inthira Yamabhai, MBA, Kakanang Chaisiri, BSPs, Sripen Tantivess, PhD, Yot Teerawattananon, PhD Health Intervention and Technology Assessment Program

Health care priority setting in Norway a multicriteria decision analysis. Thierry DefechereuxEmail author, Francesco Paolucci, Andrew Mirelman, Sitaporn Youngkong, Grete Botten, Terje P Hagen and Louis W Niessen Abstract Background Priority setting in population health is increasingly base

Health Related Quality of Life among Patient with Tuberculosis and HIV in Thailand. Wanitchaya Kittikraisak , Pritaporn Kingkaew, Yot Teerawattananon, Jomkwan Yothasamut, Supalert Natesuwan, Weerawat Manosuthi, Virasakdi Chongsuvivatwong, Sara J. Whitehead Abstract Introduction Health util